Early research (Phase 1)Study completedNCT01973439
What this trial is testing
PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months
Who this might be right for
HIV Infection
PENTA Foundation 23